Recent Advances in the Molecular Genetics of Lung Cancer

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 30 May 2025 | Viewed by 490

Special Issue Editor


E-Mail Website
Guest Editor
Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland
Interests: non-small-cell lung cancer; hypoxia; molecular basis of lung cancer; metastasis

Special Issue Information

Dear Colleagues,

The upcoming Special Issue will review recent developments and future perspectives in the field of lung cancer genetics. It is well known that lung cancer is the most common cancer and the leading cause of cancer death worldwide. Although most lung cancers, particularly non-small-cell lung cancer (NSCLC), are caused by smoking, genetics plays an important role, as less than 20% of smokers will develop the disease, and non-smokers with a family history may also have an increased risk of developing the disease. The genetics of lung cancer is complex and includes alterations in oncogenes (EGFR, KRAS, ALK, and ROS1), tumor suppressor genes (p53, RB1, and CDKN2A) and other regulatory pathways. Chromosomal abnormalities, such as EML4-ALK fusion and EGFR amplification, as well as epigenetic changes, also play an important role in lung cancer. Because lung cancer is caused by a variety of genetic alterations, it is a dynamic and evolving field. Advances in the genetic understanding of lung cancer have revolutionized treatment strategies, particularly in immunotherapy for lung cancer driven by specific oncogenes, highlighting the need for comprehensive molecular profiling to fine-tune treatment choices.

In this Special Issue, original research articles and review articles are welcome. Research areas may include (but are not limited to) the following:

  • The genetic landscape of lung cancer: oncogenes, tumor suppressor genes, chromosomal abnormalities, and gene expression profiling.
  • Epigenetic alterations: DNA methylation and histone modifications.
  • Genetic predisposition to lung cancer.
  • Genetic testing.
  • Environmental and lifestyle factors leading to lung cancer.
  • Targeted therapies.
  • Tumor microenvironment.

Dr. Iwona Ziółkowska-Suchanek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung cancer
  • molecular oncology
  • genetics
  • epigenetic alterations
  • proteomics
  • multi-omics approaches
  • immunotherapy
  • targeted therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 587 KiB  
Review
Advancements in Gene Therapy for Non-Small Cell Lung Cancer: Current Approaches and Future Prospects
by Iwona Ziółkowska-Suchanek and Natalia Rozwadowska
Genes 2025, 16(5), 569; https://doi.org/10.3390/genes16050569 - 12 May 2025
Viewed by 183
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, characterized by late diagnosis and resistance to conventional therapies. Gene therapy has emerged as a promising alternative for NSCLC therapy, especially for patients with advanced disease who have exhausted conventional [...] Read more.
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, characterized by late diagnosis and resistance to conventional therapies. Gene therapy has emerged as a promising alternative for NSCLC therapy, especially for patients with advanced disease who have exhausted conventional treatments. This article delved into the current developments in gene therapy for NSCLC, including gene replacement and tumor suppressor gene therapy, gene silencing, CRISPR/Cas9 gene editing, and immune modulation with CAR-T cell therapy. In addition, the challenges and future prospects of gene-based therapies for NSCLC were discussed. Full article
(This article belongs to the Special Issue Recent Advances in the Molecular Genetics of Lung Cancer)
Show Figures

Figure 1

Back to TopTop